Beck Bode’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Beck Bode's AZN Position: Q4 2025 in Review
Beck Bode sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 111,772 shares — an estimated $17.2M sold.
Beck Bode first reported a position in AZN in Q3 2020 and held it in 7 quarters. The position peaked at $17.2M in Q3 2025. 1,415 funds tracked by Wall St. Rank hold AZN as of Q4 2025.
- Beck Bode reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
- Beck Bode sold 111,772 AstraZeneca shares in Q4 2025, an estimated $17.2M.
- Beck Bode first reported a position in AstraZeneca in Q3 2020 and held it in 7 quarters.
- Beck Bode's AstraZeneca position peaked at $17.2M in Q3 2025.
- 1,415 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.
Based on Beck Bode's 13F filing for Q4 2025, filed 9 Feb 2026.